[25] Instead, the guidelines emphasize comprehensive cardiometabolic risk reduction through improved glycemic control, weight management, blood pressure control, and lipid management
Long-term corticosteroid use can have similar effects, additionally depleting B12
It is also evidenced to balance neurotransmitter levels, potentially addressing symptoms of Parkinsons disease, schizophrenia, and depression [2, 6, 11]
Yes, and prevention is significantly more effective and less costly than correction
In the trial mentioned above, one year after stopping the GLP-1 medication, participants also saw: Blood pressure levels go back up C-reactive protein levels (an indicator of inflammation) increase VLDL cholesterol (a type that leads to hardened arteries) goes up Triglycerides (a type of blood fat) go up Hemoglobin A1c increases (meaning the level of sugar in the blood) At high levels, these health markers are associated with conditions like type 2 diabetes, obesity, hypertension, and heart disease, to list a few
That shapes the experience: a wide-catalog membership versus a program built specifically around GLP-1 dispensing
